Search

Search Constraints

You searched for: Author/Creator Karres, Dominik

Search Results

1. ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients. (March 2020)

2. ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?. Issue 11 (November 2022)

3. ACCELERATE – Five years accelerating cancer drug development for children and adolescents. (May 2022)

4. Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T‐Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease. (14th November 2019)

5. Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this Concept. Issue 3 (8th July 2020)

7. EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors. (10th March 2020)

8. European regulatory strategy for supporting childhood cancer therapy developments. (December 2022)

9. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (September 2020)

10. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (September 2020)